HAVCR2 and breast carcinoma: Furthermore, Siglec-7 expression was positively correlated with the upregulation of a distinct panel of inhibitory molecules known to contribute to immune evasion in breast cancer, including PD-1, PD-L1, CTLA-4, TIM-3, and LAG-3 (69).